| MeSH term | MeSH ID | Detail |
|---|---|---|
| Carcinoma | D002277 | 18 associated lipids |
| Carcinoma, Non-Small-Cell Lung | D002289 | 72 associated lipids |
| Carcinoma, Papillary | D002291 | 3 associated lipids |
| Carcinosarcoma | D002296 | 7 associated lipids |
| Cardiovascular Diseases | D002318 | 24 associated lipids |
| Celiac Disease | D002446 | 16 associated lipids |
| Brain Ischemia | D002545 | 89 associated lipids |
| Cherubism | D002636 | 1 associated lipids |
| Chondroblastoma | D002804 | 1 associated lipids |
| Chondrocalcinosis | D002805 | 1 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Stilgren LS et al. | Osteoprotegerin levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism. | 2003 | Calcif. Tissue Int. | pmid:14667132 |
| Okada T et al. | Bone marrow metastatic myeloma cells promote osteoclastogenesis through RANKL on endothelial cells. | 2003 | Clin. Exp. Metastasis | pmid:14669795 |
| Sugatani T et al. | Activin A stimulates IkappaB-alpha/NFkappaB and RANK expression for osteoclast differentiation, but not AKT survival pathway in osteoclast precursors. | 2003 | J. Cell. Biochem. | pmid:12938156 |
| Min JK et al. | Vascular endothelial growth factor up-regulates expression of receptor activator of NF-kappa B (RANK) in endothelial cells. Concomitant increase of angiogenic responses to RANK ligand. | 2003 | J. Biol. Chem. | pmid:12893832 |
| Teitelbaum SL and Ross FP | Genetic regulation of osteoclast development and function. | 2003 | Nat. Rev. Genet. | pmid:12897775 |
| Yamada T et al. | Regulation of osteoclast development by Notch signaling directed to osteoclast precursors and through stromal cells. | 2003 | Blood | pmid:12411305 |
| Barillé-Nion S and Bataille R | New insights in myeloma-induced osteolysis. | 2003 | Leuk. Lymphoma | pmid:14565645 |
| Mandelin J et al. | Imbalance of RANKL/RANK/OPG system in interface tissue in loosening of total hip replacement. | 2003 | J Bone Joint Surg Br | pmid:14653607 |
| Malyszko J et al. | Osteoprotegerin and its correlations with new markers of bone formation and bone resorption in kidney transplant recipients. | 2003 | Transplant. Proc. | pmid:14529897 |
| Tazoe M et al. | Involvement of p38MAP kinase in bone morphogenetic protein-4-induced osteoprotegerin in mouse bone-marrow-derived stromal cells. | 2003 | Arch. Oral Biol. | pmid:12828991 |
| Wiethe C et al. | Provision of 4-1BB ligand enhances effector and memory CTL responses generated by immunization with dendritic cells expressing a human tumor-associated antigen. | 2003 | J. Immunol. | pmid:12626542 |
| Ueland T et al. | Age-related changes in cortical bone content of insulin-like growth factor binding protein (IGFBP)-3, IGFBP-5, osteoprotegerin, and calcium in postmenopausal osteoporosis: a cross-sectional study. | 2003 | J. Clin. Endocrinol. Metab. | pmid:12629078 |
| Lee HA et al. | Bumetanide, the specific inhibitor of Na+-K+-2Cl- cotransport, inhibits 1alpha,25-dihydroxyvitamin D3-induced osteoclastogenesis in a mouse co-culture system. | 2003 | Exp. Physiol. | pmid:12955156 |
| Yorke R et al. | Receptor activator of nuclear factor kappaB (RANK) is expressed as a late event during malignant progression in Barrett's metaplasia. | 2003 | Eur. J. Cancer | pmid:12957466 |
| Kaneyama K et al. | Expression of osteoprotegerin in synovial tissue and degradation of articular cartilage: comparison with arthroscopic findings of temporomandibular joint disorders. | 2003 | Oral Surg Oral Med Oral Pathol Oral Radiol Endod | pmid:12973279 |
| Lubberts E et al. | IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance. | 2003 | J. Immunol. | pmid:12594294 |
| Sabokbar A et al. | Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis. | 2003 | J. Orthop. Res. | pmid:12507582 |
| Elhasid R et al. | Familial severe congenital neutropenia associated with infantile osteoporosis: a new entity. | 2003 | Am. J. Hematol. | pmid:12508266 |
| Haynes DR et al. | Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls. | 2003 | Rheumatology (Oxford) | pmid:12509625 |
| Walsh MC and Choi Y | Biology of the TRANCE axis. | 2003 Jun-Aug | Cytokine Growth Factor Rev. | pmid:12787563 |
| Smith BB et al. | A toxicity profile of osteoprotegerin in the cynomolgus monkey. | 2003 Sep-Oct | Int. J. Toxicol. | pmid:14555415 |
| Theoleyre S et al. | The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling. | 2004 | Cytokine Growth Factor Rev. | pmid:15561602 |
| Mori T et al. | RNA aptamers selected against the receptor activator of NF-kappaB acquire general affinity to proteins of the tumor necrosis factor receptor family. | 2004 | Nucleic Acids Res. | pmid:15562003 |
| Ling JQ and Li JP | [Insulin-like growth factor-II and basic fibroblast growth factor affect periodontal ligament cells expressing osteoprotegerin in vitro]. | 2004 | Hua Xi Kou Qiang Yi Xue Za Zhi | pmid:15562643 |
| Kumamoto H and Ooya K | Expression of parathyroid hormone-related protein (PTHrP), osteoclast differentiation factor (ODF)/receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoclastogenesis inhibitory factor (OCIF)/osteoprotegerin (OPG) in ameloblastomas. | 2004 | J. Oral Pathol. Med. | pmid:14675140 |
| Suda K et al. | Suppression of osteoprotegerin expression by prostaglandin E2 is crucially involved in lipopolysaccharide-induced osteoclast formation. | 2004 | J. Immunol. | pmid:14764723 |
| Brubaker KD et al. | Bone morphogenetic protein signaling in prostate cancer cell lines. | 2004 | J. Cell. Biochem. | pmid:14689587 |
| Zhang D et al. | The expression of osteoprotegerin and the receptor activator of nuclear factor kappa B ligand in human periodontal ligament cells cultured with and without 1alpha,25-dihydroxyvitamin D3. | 2004 | Arch. Oral Biol. | pmid:14693199 |
| Okumura S et al. | [Regulatory mechanism of osteoclast differentiation and function]. | 2004 | Nippon Rinsho | pmid:15035103 |
| Udagawa N et al. | [Possible role of RANKL in bone resorption]. | 2004 | Nippon Rinsho | pmid:15035104 |
| Inoue D | [OPG(osteoprotegerin)/OCIF(osteoclastogenesis inhibitory factor)]. | 2004 | Nippon Rinsho | pmid:15035105 |
| Suzuki Y | [Stimulator of bone resorption interleukin-1, interleukin-6 and gp-130 cytokine family]. | 2004 | Nippon Rinsho | pmid:15035106 |
| Miyaura C | [LPS]. | 2004 | Nippon Rinsho | pmid:15035108 |
| Tanaka Y | [Adhesion molecules in the context with bone remodeling and osteoporosis]. | 2004 | Nippon Rinsho | pmid:15035110 |
| Tomoyasu A and Higashio K | [Osteoclastogenesis inhibitory factor/osteoprotegerin(OCIF/OPG)]. | 2004 | Nippon Rinsho | pmid:15035190 |
| Sohen S | [Glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis and collagen diseases]. | 2004 | Nippon Rinsho | pmid:15035207 |
| Tanaka Y | [Secondary osteoporosis due to systemic autoimmune diseases and rheumatic diseases]. | 2004 | Nippon Rinsho | pmid:15035208 |
| Fukunaga J and Sugahara T | [Osteoporosis induced by immunosuppressant]. | 2004 | Nippon Rinsho | pmid:15035219 |
| Juji T and Tanaka S | [Novel therapeutic approach to bone metabolic disorders using RANKL vaccination]. | 2004 | Nippon Rinsho | pmid:15035230 |
| Naumann U et al. | Expression and functional activity of osteoprotegerin in human malignant gliomas. | 2004 | Acta Neuropathol. | pmid:14504888 |
| Saidenberg-Kermanac'h N et al. | Interleukin-4 cellular gene therapy and osteoprotegerin decrease inflammation-associated bone resorption in collagen-induced arthritis. | 2004 | J. Clin. Immunol. | pmid:15163893 |
| Melhus H | Soluble RANKL and risk of nontraumatic fracture. | 2004 | JAMA | pmid:15187049 |
| Pennisi P et al. | Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. | 2004 | Osteoporos Int | pmid:14661073 |
| Wise GE et al. | Regulation of secretion of osteoprotegerin in rat dental follicle cells. | 2004 | Eur. J. Oral Sci. | pmid:15458504 |
| Dai SM et al. | Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha. | 2004 | Ann. Rheum. Dis. | pmid:15479886 |
| Wang JC et al. | Osteosclerosis in idiopathic myelofibrosis is related to the overproduction of osteoprotegerin (OPG). | 2004 | Exp. Hematol. | pmid:15504545 |
| Chen Q et al. | Testosterone increases osteoprotegerin mRNA expression in mouse osteoblast cells. | 2004 | Horm. Metab. Res. | pmid:15523591 |
| Saidenberg-Kermanac'h N et al. | TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis. | 2004 | Bone | pmid:15542046 |
| Boabaid F et al. | The role of parathyroid hormone-related protein in the regulation of osteoclastogenesis by cementoblasts. | 2004 | J. Periodontol. | pmid:15515341 |
| Franck H et al. | Evaluation of bone mineral density, hormones, biochemical markers of bone metabolism, and osteoprotegerin serum levels in patients with ankylosing spondylitis. | 2004 | J. Rheumatol. | pmid:15517638 |
| Price PA et al. | Serum levels of the fetuin-mineral complex correlate with artery calcification in the rat. | 2004 | J. Biol. Chem. | pmid:14578360 |
| Tian QX and Huang GY | [Effects of 1,25-dihydroxyvitamin D3 on the expressions of osteoprotegerin and receptor activator of NF-kappaB ligand in mouse osteoblasts]. | 2004 | Zhongguo Yi Xue Ke Xue Yuan Xue Bao | pmid:15379268 |
| Colucci S et al. | T cells support osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease: the role of the OPG/TRAIL interaction. | 2004 | Blood | pmid:15308561 |
| Miyazaki T et al. | Changes in receptor activator of nuclear factor-kappaB, and its ligand, osteoprotegerin, bone-type alkaline phosphatase, and tartrate-resistant acid phosphatase in ovariectomized rats. | 2004 | J. Cell. Biochem. | pmid:15372622 |
| Jeffcoate W | Vascular calcification and osteolysis in diabetic neuropathy-is RANK-L the missing link? | 2004 | Diabetologia | pmid:15322748 |
| Liu Z et al. | Production of recombinant human osteoprotegrin from Trichoplusia ni cells and Bombyx mori larvae. | 2004 | Protein Pept. Lett. | pmid:15327363 |
| Politou M et al. | Role of receptor activator of nuclear factor-kappa B ligand (RANKL), osteoprotegerin and macrophage protein 1-alpha (MIP-1a) in monoclonal gammopathy of undetermined significance (MGUS). | 2004 | Br. J. Haematol. | pmid:15327520 |
| Erdogan B et al. | Intima-media thickness of the carotid arteries is related to serum osteoprotegerin levels in healthy postmenopausal women. | 2004 | Neurol. Res. | pmid:15327755 |
| Hofbauer LC and Schoppet M | Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. | 2004 | JAMA | pmid:15280347 |
| Kanatani M et al. | Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction. | 2004 | J. Cell. Physiol. | pmid:15281085 |
| Xiao XH et al. | [Ascorbic acid inhibits the formation and function of osteoclasts from RAW264.7 cells induced by receptor activated nuclear factor kappaB ligand in vitro]. | 2004 | Zhonghua Yi Xue Za Zhi | pmid:15730627 |
| Matsuo K and Ray N | Osteoclasts, mononuclear phagocytes, and c-Fos: new insight into osteoimmunology. | 2004 | Keio J Med | pmid:15247511 |
| Tiranathanagul S et al. | Actinobacillus actinomycetemcomitans lipopolysaccharide activates matrix metalloproteinase-2 and increases receptor activator of nuclear factor-kappaB ligand expression in human periodontal ligament cells. | 2004 | J. Periodontol. | pmid:15732867 |
| Mosheimer BA et al. | Expression and function of RANK in human monocyte chemotaxis. | 2004 | Arthritis Rheum. | pmid:15248232 |
| Xu D et al. | Development of a chimaeric receptor approach to study signalling by tumour necrosis factor receptor family members. | 2004 | Biochem. J. | pmid:15250821 |
| Terpos E et al. | Autologous stem cell transplantation normalizes abnormal bone remodeling and sRANKL/osteoprotegerin ratio in patients with multiple myeloma. | 2004 | Leukemia | pmid:15215875 |
| Brändström H et al. | A single nucleotide polymorphism in the promoter region of the osteoprotegerin gene is related to intima-media thickness of the carotid artery in hypertensive patients. The Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA). | 2004 | Blood Press. | pmid:15223723 |
| Wilson SE et al. | RANK, RANKL, OPG, and M-CSF expression in stromal cells during corneal wound healing. | 2004 | Invest. Ophthalmol. Vis. Sci. | pmid:15223796 |
| Pioletti DP and Kottelat A | The influence of wear particles in the expression of osteoclastogenesis factors by osteoblasts. | 2004 | Biomaterials | pmid:15172492 |
| Livshits G et al. | Genetic influences on the circulating cytokines involved in osteoclastogenesis. | 2004 | J. Med. Genet. | pmid:15173242 |
| De Wilde A et al. | A low dose of daidzein acts as an ERbeta-selective agonist in trabecular osteoblasts of young female piglets. | 2004 | J. Cell. Physiol. | pmid:15174095 |
| Ueland T et al. | Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction. | 2004 | J. Am. Coll. Cardiol. | pmid:15542278 |
| Taranta A et al. | Imbalance of osteoclastogenesis-regulating factors in patients with celiac disease. | 2004 | J. Bone Miner. Res. | pmid:15176994 |
| Demer LL and Abedin M | Skeleton key to vascular disease. | 2004 | J. Am. Coll. Cardiol. | pmid:15542279 |
| Coetzee M and Kruger MC | Osteoprotegerin-receptor activator of nuclear factor-kappaB ligand ratio: a new approach to osteoporosis treatment? | 2004 | South. Med. J. | pmid:15180028 |
| Vidal K et al. | Osteoprotegerin production by human intestinal epithelial cells: a potential regulator of mucosal immune responses. | 2004 | Am. J. Physiol. Gastrointest. Liver Physiol. | pmid:15521102 |
| Abedin M et al. | Vascular calcification: mechanisms and clinical ramifications. | 2004 | Arterioscler. Thromb. Vasc. Biol. | pmid:15155384 |
| Vidal K et al. | Osteoprotegerin in human milk: a potential role in the regulation of bone metabolism and immune development. | 2004 | Pediatr. Res. | pmid:15155868 |
| Grzegorzewska AE and MÅ‚ot M | Ratio of cyclase activating and cyclase inactive parathormone (CAP/CIP) in dialysis patients: correlations with other markers of bone disease. | 2004 | Rocz. Akad. Med. Bialymst. | pmid:15631341 |
| Grzegorzewska AE and MÅ‚ot M | Serum osteoprotegerin level is lower in peritoneal dialysis patients than in hemodialysis ones. | 2004 | Rocz. Akad. Med. Bialymst. | pmid:15631342 |
| Naumnik W et al. | Serum levels of osteoprotegerin (OPG) and pro gastrin releasing peptide (ProGRP) during chemotherapy of lung cancer. | 2004 | Rocz. Akad. Med. Bialymst. | pmid:15638385 |
| Franchimont N et al. | Increased expression of receptor activator of NF-kappaB ligand (RANKL), its receptor RANK and its decoy receptor osteoprotegerin in the colon of Crohn's disease patients. | 2004 | Clin. Exp. Immunol. | pmid:15544627 |
| Eaton CL et al. | Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer. | 2004 | Prostate | pmid:15042606 |
| O' Gradaigh D et al. | Joint erosion in rheumatoid arthritis: interactions between tumour necrosis factor alpha, interleukin 1, and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclasts. | 2004 | Ann. Rheum. Dis. | pmid:15020327 |
| Ichinose Y et al. | Osteoclastogenesis inhibitory factor/osteoprotegerin reduced bone loss induced by mechanical unloading. | 2004 | Calcif. Tissue Int. | pmid:15549649 |
| Collantes Estévez E and González DomÃnguez J | [Bone Paget's disease in the young adult]. | 2004 | Rev Clin Esp | pmid:15456600 |
| Collin-Osdoby P | Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin. | 2004 | Circ. Res. | pmid:15564564 |
| Sato N et al. | MyD88 but not TRIF is essential for osteoclastogenesis induced by lipopolysaccharide, diacyl lipopeptide, and IL-1alpha. | 2004 | J. Exp. Med. | pmid:15353553 |
| Mizutani Y et al. | Prognostic significance of serum osteoprotegerin levels in patients with bladder carcinoma. | 2004 | Cancer | pmid:15386310 |
| Haynes DR et al. | Regulation of osteoclast activity in peri-implant tissues. | 2004 | Biomaterials | pmid:15109848 |
| Ito S and Hata T | Crystal structure of RANK ligand involved in bone metabolism. | 2004 | Vitam. Horm. | pmid:15110169 |
| Hao C et al. | Modulation of TRAIL signaling complex. | 2004 | Vitam. Horm. | pmid:15110173 |
| Kiechl S et al. | Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease. | 2004 | Circulation | pmid:15117849 |
| Pritzker LB et al. | The role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand in human microvascular endothelial cell survival. | 2004 | Mol. Biol. Cell | pmid:15064358 |
| Salmon P | Loss of chaotic trabecular structure in OPG-deficient juvenile Paget's disease patients indicates a chaogenic role for OPG in nonlinear pattern formation of trabecular bone. | 2004 | J. Bone Miner. Res. | pmid:15068491 |
| Morabito N et al. | Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: new pieces of the puzzle. | 2004 | J. Bone Miner. Res. | pmid:15068494 |
| Durán A et al. | The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis. | 2004 | Dev. Cell | pmid:14960283 |
| Altun A et al. | Decreased serum osteoprotegerin levels in patients with cardiac syndrome X. | 2004 | J. Endocrinol. Invest. | pmid:15648548 |
| Kanzaki H et al. | Local OPG gene transfer to periodontal tissue inhibits orthodontic tooth movement. | 2004 | J. Dent. Res. | pmid:15557398 |
| Zhang X et al. | Synovial fibroblasts infected with Salmonella enterica serovar Typhimurium mediate osteoclast differentiation and activation. | 2004 | Infect. Immun. | pmid:15557643 |